Christopher Grosso

Board Member

Equibles does not estimate personal net worth.

Get an email with a short summary when Radnostix Inc publishes a filing, an earnings call transcript or a press release.

Get INIS alerts

About Christopher Grosso

Christopher Grosso is recorded as Board Member at Radnostix Inc (INIS) since July 16, 2026. Radnostix Inc reported in an 8-K filed July 21, 2026 that Christopher Grosso was appointed director, effective July 16, 2026. Radnostix Inc is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at Radnostix Inc includes Shahe Bagderjian (CEO and Board Member), Shahe Bagerdjian (CEO and Board Member), Laurie McKenzie-Carter (CFO) and 6 others.

“Proposal 1: Election of five directors to serve for a term of one year and until their successors are elected and qualified.”

Radnostix Inc Form 8-K, filed July 21, 2026 · Read the filing

Affiliation history

Radnostix Inc (INIS)
Board Member

SEC 8-K

Current
2026-07-16–present

Company network

Radnostix Inc

INIS

Current role

Drug Manufacturers - Specialty & Generic · Healthcare

Board Member

2026-07-16–present

Leadership on record at Radnostix Inc

Shahe Bagderjian CEO, Board Member
Shahe Bagerdjian CEO, Board Member
Laurie McKenzie-Carter CFO
W. Matthew Cox CFO
Dr. Duke W. Fu Board Member
Duke Fu Board Member
Duke W. Fu Board Member
Robert Atcher Board Member
Steve Laflin Board Member

Recent activity

Executive change Appointed: director Radnostix Inc (INIS)
2026-07-16